EGFR and non-small cell lung carcinoma: Hsa_circ_0000190 can similarly regulate epidermal growth factor receptor (EGFR)/extracellular regulated protein kinases (ERK) pathway activity in a manner beneficial to NSCLC tumor cells [10].